Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Epilepsia
|
December 24, 2025
A call for ethical, equitable, and effective artificial intelligence to improve care for all people with epilepsy: A roadmap. A report by the ILAE Global Advocacy Council and Big Data Commission
Colin B Josephson, Sandor Beniczky, Spiros Denaxas, et al.
PLOS Digital Health
|
February 12, 2025
Evaluating the generalisability of region-naïve machine learning algorithms for the identification of epilepsy in low-resource settings
Ioana Duta, Symon M Kariuki, Anthony K Ngugi, et al.
PLOS Digital Health
|
April 17, 2025
Correction: Evaluating the generalisability of region-naïve machine learning algorithms for the identification of epilepsy in low-resource settings
Ioana Duta, Symon M Kariuki, Anthony K Ngugi, et al.
Plos One
|
October 30, 2023
Leveraging a smartphone to perform time-gated luminescence measurements
Brian E Fratto, Emma L Culver, Gabriel Davis, et al.
Global Epidemiology
|
January 26, 2026
Modelling seizure-related predictors of epilepsy diagnostic gap in two urban informal settlements of Nairobi using machine learning
Daniel Mwanga, Frederick Murunga Wekesah, Frank Ouma, et al.
Neurology. Genetics
|
December 28, 2018
Development of a rapid functional assay that predicts GLUT1 disease severity
Sasha M Zaman, Saul A Mullen, Slavé Petrovski, et al.
The Lancet. Global Health
|
July 8, 2024
Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based study
Daniel M Mwanga, Damazo T Kadengye, Peter O Otieno, et al.
Trials
|
August 1, 2021
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
Arjune Sen, Mary Akinola, Xin You Tai, et al.
Epilepsia Open
|
October 14, 2024
Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial
Arjune Sen, Sofia Toniolo, Xin You Tai, et al.
Epilepsia Open
|
September 3, 2024
The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study
Michael J Vasey, Xin You Tai, Jennifer Thorpe, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Epilepsia
|
December 24, 2025
A call for ethical, equitable, and effective artificial intelligence to improve care for all people with epilepsy: A roadmap. A report by the ILAE Global Advocacy Council and Big Data Commission
Colin B Josephson, Sandor Beniczky, Spiros Denaxas, et al.
PLOS Digital Health
|
February 12, 2025
Evaluating the generalisability of region-naïve machine learning algorithms for the identification of epilepsy in low-resource settings
Ioana Duta, Symon M Kariuki, Anthony K Ngugi, et al.
PLOS Digital Health
|
April 17, 2025
Correction: Evaluating the generalisability of region-naïve machine learning algorithms for the identification of epilepsy in low-resource settings
Ioana Duta, Symon M Kariuki, Anthony K Ngugi, et al.
Plos One
|
October 30, 2023
Leveraging a smartphone to perform time-gated luminescence measurements
Brian E Fratto, Emma L Culver, Gabriel Davis, et al.
Global Epidemiology
|
January 26, 2026
Modelling seizure-related predictors of epilepsy diagnostic gap in two urban informal settlements of Nairobi using machine learning
Daniel Mwanga, Frederick Murunga Wekesah, Frank Ouma, et al.
Neurology. Genetics
|
December 28, 2018
Development of a rapid functional assay that predicts GLUT1 disease severity
Sasha M Zaman, Saul A Mullen, Slavé Petrovski, et al.
The Lancet. Global Health
|
July 8, 2024
Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based study
Daniel M Mwanga, Damazo T Kadengye, Peter O Otieno, et al.
Trials
|
August 1, 2021
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
Arjune Sen, Mary Akinola, Xin You Tai, et al.
Epilepsia Open
|
October 14, 2024
Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial
Arjune Sen, Sofia Toniolo, Xin You Tai, et al.
Epilepsia Open
|
September 3, 2024
The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study
Michael J Vasey, Xin You Tai, Jennifer Thorpe, et al.
Page
of 3